At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 66 enrolled
Drug / intervention
Fentanyl/Hydromorphone +1 moredrug
Likely dose
Methadone 0.1mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pediatric Pain Optimization After Tonsillectomy: A Randomized Double Blind Methadone Pilot Study
In Brief
A Phase 2 clinical trial evaluating Fentanyl/Hydromorphone and Methadone for Obstructive Sleep Apnea and 2 related conditions. Completed, enrolled 66 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea, Tonsillitis, Pain, Procedural
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2023202420252026
First PostedFeb 2022
Enrollment StartApr 2022
Primary CompletionMay 2023
TodayJul 2026
First PostedFeb 17, 2022
Enrollment StartApr 8, 2022
Primary CompletionMay 10, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.4 years ago
Interventions
Fentanyl/Hydromorphonedrug
Per routine care
Methadonedrug
Initial dosing 0.1mg/kg, potential to escalate to 0.15mg/kg following interim analysis